Literature DB >> 28360731

Association of Demyelinating and Inflammatory Bowel Diseases: A Case Series and Overview of the Literature.

Murat Mert Atmaca1, Güneş Altiokka Uzun1, Erkingül Shugaiv2, Murat Kürtüncü1, Mefküre Eraksoy1.   

Abstract

Neurological complications of inflammatory bowel diseases (i.e., ulcerative colitis and Crohn's disease) can be summarized as a combination of neuromuscular manifestations, cerebrovascular and demyelinating diseases that can be seen in approximately 3% of patients. In addition, asymptomatic cerebral white matter lesions may be detected in these patients. Clustering of diseases within families may be explained by the exposure to similar environmental factors, shared genes, or complex interactions between genetic and environmental factors. Here we report an epileptic patient with Crohn's disease and cerebral white matter lesions, a family with ulcerative colitis and multiple sclerosis and two patients who have both multiple sclerosis and Crohn's disease.

Entities:  

Keywords:  Crohn’s disease; Inflammatory bowel diseases; epilepsia partialis continua; multiple sclerosis; ulcerative colitis

Year:  2015        PMID: 28360731      PMCID: PMC5353069          DOI: 10.5152/npa.2015.8725

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  18 in total

1.  Neurologic disorders associated with inflammatory bowel disease.

Authors:  L Benavente; G Morís
Journal:  Eur J Neurol       Date:  2011-01       Impact factor: 6.089

Review 2.  Inflammatory bowel disease: clinical aspects and established and evolving therapies.

Authors:  Daniel C Baumgart; William J Sandborn
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

Review 3.  Inflammatory bowel disease: cause and immunobiology.

Authors:  Daniel C Baumgart; Simon R Carding
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

4.  Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.

Authors:  Lindsey A Criswell; Kirsten A Pfeiffer; Raymond F Lum; Bonnie Gonzales; Jill Novitzke; Marlena Kern; Kathy L Moser; Ann B Begovich; Victoria E H Carlton; Wentian Li; Annette T Lee; Ward Ortmann; Timothy W Behrens; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2005-02-17       Impact factor: 11.025

5.  The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.

Authors:  C N Bernstein; J F Blanchard; P Rawsthorne; N Yu
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

6.  Increased risk for demyelinating diseases in patients with inflammatory bowel disease.

Authors:  Gauree Gupta; Joel M Gelfand; James D Lewis
Journal:  Gastroenterology       Date:  2005-09       Impact factor: 22.682

Review 7.  Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics.

Authors:  Siddharth Singh; Neeraj Kumar; Edward V Loftus; Sunanda V Kane
Journal:  Inflamm Bowel Dis       Date:  2013 Mar-Apr       Impact factor: 5.325

Review 8.  HLA , CTLA-4 and PTPN22 : the shared genetic master-key to autoimmunity?

Authors:  Oliver Brand; Stephen Gough; Joanne Heward
Journal:  Expert Rev Mol Med       Date:  2005-10-17       Impact factor: 5.600

9.  Autoimmune disease in families with multiple sclerosis: a population-based study.

Authors:  Sreeram Varadharajan Ramagopalan; David Alexandre Dyment; William Valdar; Blanca Marcela Herrera; Maria Criscuoli; Irene Mei Ling Yee; Adele Dessa Sadovnick; George Cornell Ebers
Journal:  Lancet Neurol       Date:  2007-07       Impact factor: 44.182

10.  Cancer risk among patients with multiple sclerosis and their parents.

Authors:  S Bahmanyar; S M Montgomery; J Hillert; A Ekbom; T Olsson
Journal:  Neurology       Date:  2009-03-31       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.